We are live on !
Find out more
ABC Arbitrage Portfolio holdings
AUM
$1.02B
Turnover
53.6%
1-Year Est. Return
30.46%
This Fund
S&P 500
This Quarter Est. Return
+11.6%
1 Year Est. Return
+30.46%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$52.3M
(+5.2%)
Cap. Flow
-$17.4M
Cap. Flow % of AUM
Cap. Flow %
-1.63%
Top 10 Holdings %
Top 10 Hldgs %
36.49%
Holding
431
New
231
Increased
44
Reduced
32
Closed
118
Avg Time Held
0.2
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Harmony Gold Mining
HMY
|
+$27.4M |
| 2 |
GSK
GSK
|
+$23.4M |
| 3 |
Novartis
NVS
|
+$23.1M |
| 4 |
Diageo
DEO
|
+$13M |
| 5 |
Barclays
BCS
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$47.5M |
| 2 |
Tenaris
TS
|
+$27.7M |
| 3 |
Sibanye-Stillwater
SBSW
|
+$27.6M |
| 4 |
RELX
RELX
|
+$23.1M |
| 5 |
STMicroelectronics
STM
|
+$17.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.09% |
| 2 | Healthcare | 15.65% |
| 3 | Consumer Staples | 11.29% |
| 4 | Materials | 11.29% |
| 5 | Technology | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
British American Tobacco
BTI
$129B
| $52M | 4.87% |
918,653
+147,630
| +19% | +$8.06M |
2024 Q4
4 quarters
|
|
|
2
Harmony Gold Mining
HMY
$10.2B
| $49.5M | 4.64% |
2,488,874
+1,467,370
| +144% | +$27.4M |
2025 Q3
1 quarter
|
|
|
3
Diageo
DEO
$51.8B
| $48.3M | 4.53% |
560,383
+141,301
| +34% | +$13M |
2024 Q4
4 quarters
|
|
4
Vodafone
VOD
$36.5B
| $42.6M | 3.99% |
3,227,589
-418,823
| -11% | -$5.07M |
2024 Q4
4 quarters
|
|
5
Ericsson
ERIC
$35.9B
| $42.4M | 3.97% |
4,389,009
+1,179,194
| +37% | +$11.2M |
2025 Q1
3 quarters
|
|
|
6
Barclays
BCS
$74.7B
| $39.4M | 3.69% |
1,546,396
+586,115
| +61% | +$13M |
2025 Q2
2 quarters
|
|
7
DELISTED
Carnival PLC
CUK
| $30.6M | 2.86% |
1,008,794
+12,219
| +1% | +$315K |
2024 Q4
4 quarters
|
|
|
8
GSK
GSK
$102B
| $28.4M | 2.66% |
578,392
+501,590
| +653% | +$23.4M |
2025 Q3
1 quarter
|
|
9
HSBC
HSBC
$294B
| $28.3M | 2.65% |
360,332
+116,163
| +48% | +$8.31M |
2024 Q4
4 quarters
|
|
10
Haleon
HLN
$44.3B
| $28.2M | 2.64% |
2,789,451
+62,101
| +2% | +$590K |
2025 Q1
3 quarters
|
|
11
Rio Tinto
RIO
$139B
| $27.1M | 2.54% |
338,891
-56,530
| -14% | -$4.07M |
2024 Q4
4 quarters
|
|
12
NatWest
NWG
$66.7B
| $24.9M | 2.34% |
1,425,146
+322,175
| +29% | +$5.11M |
2024 Q4
4 quarters
|
|
|
13
Sibanye-Stillwater
SBSW
$6.67B
| $24.9M | 2.33% |
1,749,026
-2,283,786
| -57% | -$27.6M |
2025 Q2
2 quarters
|
|
14
Smith & Nephew
SNN
$12.6B
| $24.9M | 2.33% |
757,956
+74,504
| +11% | +$2.55M |
2024 Q4
4 quarters
|
|
|
15
Novartis
NVS
$296B
| $24.4M | 2.28% |
+176,749
| New | +$23.1M |
2025 Q4
0 quarters
|
|
16
National Grid
NGG
$82.2B
| $24.1M | 2.26% |
312,202
+69,204
| +28% | +$5.21M |
2024 Q4
4 quarters
|
|
17
Shell
SHEL
$298B
| $23.6M | 2.21% |
321,821
+140,966
| +78% | +$10.4M |
2025 Q1
3 quarters
|
|
18
Aegon
AEG
$12.2B
| $16.2M | 1.51% |
2,097,310
+15,442
| +0.7% | +$118K |
2025 Q3
1 quarter
|
|
19
ING
ING
$92.5B
| $15.6M | 1.46% |
556,894
-344,042
| -38% | -$8.87M |
2024 Q4
4 quarters
|
|
20
InterContinental Hotels
IHG
$24.2B
| $14.4M | 1.35% |
102,505
-28,872
| -22% | -$3.75M |
2025 Q2
2 quarters
|
|
21
iShares China Large-Cap ETF
FXI
$3.72B
| $13.9M | 1.3% |
362,554
-44,553
| -11% | -$1.77M |
2025 Q3
1 quarter
|
|
|
22
AstraZeneca
AZN
$264B
| $12.9M | 1.21% |
70,075
-270,606
| -79% | -$47.5M |
2025 Q1
3 quarters
|
|
23
BP
BP
$126B
| $12.9M | 1.21% |
370,972
+41,260
| +13% | +$1.45M |
2024 Q4
4 quarters
|
|
24
Rentokil
RTO
$11.5B
| $10.9M | 1.02% |
369,604
-64,968
| -15% | -$1.8M |
2025 Q1
3 quarters
|
|
25
Unilever
UL
$140B
| $7.68M | 0.72% |
117,480
+40,036
| +52% | +$2.69M |
2024 Q4
4 quarters
|
|
Similar funds
PS
JPC
ABC Arbitrage's Q4 2025 Portfolio in Review
As of Q4 2025, ABC Arbitrage held 431 positions worth $1.07B, up 5.2% from $1.02B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
ABC Arbitrage's Q4 2025 filing shows 231 new, 44 increased, 32 reduced and 118 closed positions. Its largest new stake was Novartis: 176,749 shares worth $24.4M. The largest sale was AstraZeneca, an estimated $47.5M.
By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Staples.
- ABC Arbitrage's largest Q4 2025 buy was Novartis: 176,749 shares worth $24.4M.
- ABC Arbitrage added most to Harmony Gold Mining in Q4 2025, an estimated $27.4M increase.
- ABC Arbitrage's biggest Q4 2025 reduction was AstraZeneca, cutting an estimated $47.5M.
- ABC Arbitrage fully exited Tenaris in Q4 2025, selling an estimated $27.7M.
- ABC Arbitrage's ten largest holdings make up 36% of its $1.07B portfolio in Q4 2025.
- ABC Arbitrage opened 231 new positions and closed 118 in Q4 2025.
- ABC Arbitrage's portfolio value rose 5.2% quarter-over-quarter to $1.07B.
Based on ABC Arbitrage's 13F filing for Q4 2025, filed 4 Feb 2026.